We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

30 hedge funds and large institutions have $23.7M invested in Vicarious Surgical in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $10.4M → $23.7M (+$13.2M)

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.88% less ownership

Funds ownership: 35.11%34.23% (-0.88%)

12% less funds holding

Funds holding: 3430 (-4)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
2
Increased
8
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VS
1
VK Services
California
$12.7M
DP
2
DDD Partners
Washington
$2.44M -$478K -46,453 -20%
MAMHA
3
MY.Alpha Management HK Advisors
Hong Kong
$2.4M
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.72M
AMH
5
Aspex Management (HK)
Hong Kong
$1.14M
CFM
6
Comprehensive Financial Management
California
$909K
Millennium Management
7
Millennium Management
New York
$625K -$48.5K -4,711 -9%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$405K +$24K +2,336 +8%
BlackRock
9
BlackRock
New York
$283K
DnB Asset Management
10
DnB Asset Management
Norway
$279K +$38K +3,692 +21%
MAM
11
Maytree Asset Management
Hong Kong
$235K
BCM
12
Bridgeway Capital Management
Texas
$155K
Renaissance Technologies
13
Renaissance Technologies
New York
$152K +$12.3K +1,200 +12%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$73K +$2.54K +247 +5%
JP Morgan Chase
15
JP Morgan Chase
New York
$46.5K +$21K +2,044 +137%
Morgan Stanley
16
Morgan Stanley
New York
$30.2K +$17.9K +1,739 +313%
Osaic Holdings
17
Osaic Holdings
Arizona
$25.7K +$4.29K +417 +27%
AF
18
Allworth Financial
California
$14K
TRCT
19
Tower Research Capital (TRC)
New York
$6.26K -$5.64K -548 -54%
BNP Paribas Financial Markets
20
BNP Paribas Financial Markets
France
$4.55K -$9.91K -963 -74%
AAP
21
Arax Advisory Partners
Colorado
$3.98K
FFWM
22
Future Financial Wealth Management
Ohio
$2.76K +$1.48K +144 +218%
PNC Financial Services Group
23
PNC Financial Services Group
Pennsylvania
$2.19K
SS
24
SBI Securities
Japan
$1.41K +$1.1K +107 New
UBS Group
25
UBS Group
Switzerland
$395 +$309 +30 New

RBOT Hedge Fund Activity: Q4 2024 in Review

30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2024, worth a combined $23.7M — up 126% from $10.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of RBOT and 2 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was DnB Asset Management, adding an estimated $38K. The largest seller was DDD Partners, cutting an estimated $478K.

  • 30 institutional investors held Vicarious Surgical (RBOT) as of Q4 2024, down from 34 in Q3 2024.
  • Funds reported $23.7M of Vicarious Surgical stock for Q4 2024, up 126% quarter-over-quarter.
  • 2 funds opened new Vicarious Surgical positions in Q4 2024 and 6 closed out, a net change of -4 holders.
  • The largest Vicarious Surgical buyer in Q4 2024 was DnB Asset Management, an estimated $38K added.
  • The largest Vicarious Surgical seller in Q4 2024 was DDD Partners, an estimated $478K sold.

Based on aggregated 13F filings for Q4 2024.